乙酰溴-Alpha-D-葡萄糖酮酸甲基酯结构式
|
常用名 | 乙酰溴-Alpha-D-葡萄糖酮酸甲基酯 | 英文名 | Methyl acetobromo-α-D-glucuronate |
---|---|---|---|---|
CAS号 | 21085-72-3 | 分子量 | 397.173 | |
密度 | 1.5±0.1 g/cm3 | 沸点 | 388.6±42.0 °C at 760 mmHg | |
分子式 | C13H17BrO9 | 熔点 | 80-110 °C(lit.) | |
MSDS | 中文版 美版 | 闪点 | 188.8±27.9 °C |
中文名 | 乙酰溴-Alpha-D-葡萄糖酮酸甲基酯 |
---|---|
英文名 | Acetobromo-α-D-glucuronic Acid Methyl Ester |
中文别名 | 乙酰溴-alpha-D-葡萄糖醛酸甲酯 | Α-D -葡萄糖醛酸甲基酯 | 乙酰溴-α-D-葡萄糖醛酸甲酯 | 1-溴-1-脱氧-2,3,4-三-O-乙酰基-ALPHA-D-葡萄糖醛酸甲酯 | 乙酰溴-Α-D-葡萄糖酮酸甲基酯 |
英文别名 | 更多 |
密度 | 1.5±0.1 g/cm3 |
---|---|
沸点 | 388.6±42.0 °C at 760 mmHg |
熔点 | 80-110 °C(lit.) |
分子式 | C13H17BrO9 |
分子量 | 397.173 |
闪点 | 188.8±27.9 °C |
精确质量 | 396.005585 |
PSA | 114.43000 |
LogP | 2.20 |
外观性状 | 白色结晶固体 |
蒸汽压 | 0.0±0.9 mmHg at 25°C |
折射率 | 1.505 |
储存条件 | -20°C冷藏、密闭、干燥处 |
稳定性 | 按规定使用和贮存的不会分解,避氧化物 |
更多 | 1. 性状:白色结晶 2. 密度(g/mL25 ºC):未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):80-110 5. 沸点(ºC,常压):未确定 6. 沸点(ºC,3hPa):未确定 7. 折射率:未确定 8. 闪点(ºC):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):未确定 11. 蒸气压(mmHg,20 ºC):未确定 12. 饱和蒸气压(kPa,60ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(正辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:未确定 |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危害码 (欧洲) | Xi |
安全声明 (欧洲) | S22-S24/25 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
海关编码 | 2932999099 |
乙酰溴-Alpha-D-葡萄糖酮酸甲基酯上游产品 9 | |
---|---|
乙酰溴-Alpha-D-葡萄糖酮酸甲基酯下游产品 10 | |
海关编码 | 2932999099 |
---|---|
中文概述 | 2932999099. 其他仅含氧杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途 |
Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Mitochondrial KATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts.
Am. J. Physiol. Heart Circ. Physiol. 299 , H175-183, (2010) The mechanisms responsible for anti-arrhythmic protection during ischemia-reperfusion (IR) in exercised hearts are not fully understood. The purpose of this investigation was to examine whether the AT... |
|
Glucuronidation of HMR1098 in human microsomes: evidence for the involvement of UGT1A1 in the formation of S-glucuronides.
Drug Metab. Dispos. 31 , 1027-1034, (2003) HMR1098, a novel KATP-blocking agent, is metabolized to form an S-glucuronide in rat and dog bile. Synthesis of the S-glucuronide metabolite was studied in human liver and kidney microsomes. Recombina... |
|
Single channel studies of the ATP-regulated potassium channel in brain mitochondria.
J. Bioenerg. Biomembr. 41 , 323-334, (2009) Mitochondrial potassium channels in the brain have been suggested to have an important role in neuroprotection. The single channel activity of mitochondrial potassium channels was measured after recon... |
Acetobromo-α-D-glucuronic acid, methyl ester |
Methyl 2,3,4-tri-O-acetyl-α-D-glucopyranosyluronate bromide |
Methyl acetobromo-α-D-glucuronate |
Acetobromo-α-D-glucuronic acid methyl ester |
EINECS 244-203-4 |
(2R,3R,4S,5S,6S)-2-Bromo-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
Acetobromo-alpha-D-glucuronic acid methyl ester |
α-D-Glucopyranuronic acid, 1-bromo-1-deoxy-, methyl ester, triacetate |
α-D-Glucopyranuronosyl bromide, methyl ester, triacetate |
MFCD00061613 |